PTJ
ABVX

Paul Tudor Jones’s Abivax ABVX Stock Holding History

Paul Tudor Jones’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25M Buy
187,335
+85,724
+84% +$9.7M 0.03% 391
2026
Q1 		$11.3M Buy
101,611
+73,075
+256% +$8.65M 0.02% 674
2025
Q4 		$3.85M Sell
28,536
-4,347
-13% -$474K 0.01% 1318
2025
Q3 		$2.79M Buy
+32,883
New +$2.02M ﹤0.01% 1590
2024
Q1 		– Sell
-24,500
Closed -$262K – 2153
2023
Q4 		$262K Buy
+24,500
New +$250K ﹤0.01% 2091

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Paul Tudor Jones's ABVX Position: Q2 2026 in Review

Paul Tudor Jones increased its Abivax (ABVX) stake by 84% in Q2 2026, buying an estimated $9.7M and bringing the position to 187,335 shares worth $25M. The position accounts for 0.03% of the portfolio, ranked #391.

Paul Tudor Jones first reported a position in ABVX in Q4 2023 and has held it in 5 quarters since. 302 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

  • Paul Tudor Jones held 187,335 shares of Abivax worth $25M as of Q2 2026.
  • Paul Tudor Jones bought 85,724 Abivax shares in Q2 2026, an estimated $9.7M.
  • Abivax made up 0.03% of Paul Tudor Jones's portfolio in Q2 2026, its #391 holding.
  • Paul Tudor Jones first reported a position in Abivax in Q4 2023 and has held it in 5 quarters since.
  • 302 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on Tudor Investment Corp's 13F filing for Q2 2026, filed 14 Aug 2026.